Cite
HARVARD Citation
Roy, L. et al. (2023). Dasatinib plus Peg‐Interferon alpha 2b combination in newly diagnosed chronic phase chronic myeloid leukaemia: Results of a multicenter phase 2 study (DASA‐PegIFN study). British journal of haematology. pp. 175-186. [Online].